Related references
Note: Only part of the references are listed.The coronavirus disease 2019 and effect on liver function: a hidden and vital interaction beyond the respiratory system
Parastoo Hosseini et al.
REVIEWS AND RESEARCH IN MEDICAL MICROBIOLOGY (2022)
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status
Hui Du et al.
ALLERGY (2021)
Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes
Aline H. de Nooijer et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
A comprehensive review on sarilumab in COVID-19
Sajad Khiali et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
Massimo Cugno et al.
JOURNAL OF AUTOIMMUNITY (2021)
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred et al.
PHARMACOLOGICAL REVIEWS (2021)
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week
Paloma Troyano-Hernaez et al.
VIRUSES-BASEL (2021)
Complement cascade in severe forms of COVID-19: Recent advances in therapy
Nassima Chouaki Benmansour et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
Gyorgy Sinkovits et al.
FRONTIERS IN IMMUNOLOGY (2021)
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
Lina Ma et al.
SCIENCE IMMUNOLOGY (2021)
Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
Angelo Zinellu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Youssif M. Ali et al.
FRONTIERS IN IMMUNOLOGY (2021)
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data
Natalie M. Linton et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
Diarrhea Is Associated With Prolonged Symptoms and Viral Carriage in Corona Virus Disease 2019
Xiao-Shan Wei et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
Complement activation in patients with COVID-19: A novel therapeutic target
Massimo Cugno et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
Maria Romano et al.
CELLS (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Sara Mastaglio et al.
CLINICAL IMMUNOLOGY (2020)
Rationale for targeting complement in COVID-19
Anastasia Polycarpou et al.
EMBO MOLECULAR MEDICINE (2020)
C1 esterase inhibitor and the contact system in COVID-19
Timothy M. Thomson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Complement C5 inhibition in patients with COVID-19-a promising target?
Regis Peffault de Latour et al.
HAEMATOLOGICA (2020)
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
Alessandro Rambaldi et al.
IMMUNOBIOLOGY (2020)
Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics
Jack Mellors et al.
FRONTIERS IN IMMUNOLOGY (2020)
Coronavirus Disease 2019: Associated Multiple Organ Damage
Olivier Collange et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
The complement system in COVID-19: friend and foe?
Anuja Java et al.
JCI INSIGHT (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
Jeffrey Laurence et al.
CLINICAL IMMUNOLOGY (2020)
Covid-19: Time for a paradigm change
Franco M. Buonaguro et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Targeting Proteases for Treating COVID-19
Binquan Luan et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals
Ruxing Zhao et al.
MEDIATORS OF INFLAMMATION (2020)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan C. Holter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
COVID-19 Usurps Host Regulatory Networks
Colleen S. Curran et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
Cecilia Beatrice Chighizola et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Immune Response and Immunopathology of COVID-19
Esmaeil Mortaz et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
Pascal Urwyler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study
Shilin Fang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review
Niloofar Deravi et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Indwiani Astuti et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
severe Acute Respiratory Syndrome Coronavirus-2 SARS-CoV-2 An Update
Mahendra Pal et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
Maria Prendecki et al.
CLINICAL KIDNEY JOURNAL (2020)
Links Between Complement Activation and Thrombosis
Wolfram Ruf
BLOOD (2019)
Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
Peihua Niu et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Role of C-Reactive Protein at Sites of Inflammation and Infection
Nicola R. Sproston et al.
FRONTIERS IN IMMUNOLOGY (2018)
Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways
Charithani B. Keragala et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Therapeutic Inhibition of Complement: Well Worth the Risk
Scott R. Barnum
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Complement Evasion Strategies of Viruses: An Overview
Palak Agrawal et al.
FRONTIERS IN MICROBIOLOGY (2017)
Complement, a target for therapy in inflammatory and degenerative diseases
B. Paul Morgan et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The role of C5a in acute lung injury induced by highly pathogenic viral infections
Renxi Wang et al.
EMERGING MICROBES & INFECTIONS (2015)
The mercurial nature of neutrophils: still an enigma in ARDS?
Andrew E. Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
Peter Hillmen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Role of Complement in Multiorgan Failure
Daniel Rittirsch et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
C1-esterase inhibitor infusion increases survival rates for patients with sepsis
Anton A. Igonin et al.
CRITICAL CARE MEDICINE (2012)
Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a
Hydar Ali
IMMUNOLOGY LETTERS (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Recent developments in low molecular weight complement inhibitors
Hongchang Qu et al.
MOLECULAR IMMUNOLOGY (2009)
Modulation of murine dendritic cell function by adenine nucleotides and adenosine:: Involvement of the A2B receptor
Abduelhakem Ben Addi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Functional roles for C5a receptors in sepsis
Daniel Rittirsch et al.
NATURE MEDICINE (2008)
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Mark J. Cameron et al.
VIRUS RESEARCH (2008)
Complement-targeted therapeutics
Daniel Ricklin et al.
NATURE BIOTECHNOLOGY (2007)
The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
Rikke Leth-Larsen et al.
IMMUNOBIOLOGY (2007)
Complement and coagulation: strangers or partners in crime?
Maciej M. Markiewski et al.
TRENDS IN IMMUNOLOGY (2007)
Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection
WKE Ip et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Antibody-dependent enhancement of virus infection and disease
SMC Tirado et al.
VIRAL IMMUNOLOGY (2003)
Inhibition of complement neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits
M Fung et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Share Paper
